US Senate probes gene-therapy trials

US Senate probes gene-therapy trials

In response to revelations of deficiencies in reporting of adverse events in gene-therapy trials, the US Senate Subcommittee on Public Health held a hearing on gene therapy on Feb 2.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2000-02, Vol.355 (9203), p.560-560
1. Verfasser: Rowe, Paul M
Format: Artikel
Sprache:eng
Schlagworte:
Clinical trials
Gene therapy
Hearings & confirmations
Investigations
Public health
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In response to revelations of deficiencies in reporting of adverse events in gene-therapy trials, the US Senate Subcommittee on Public Health held a hearing on gene therapy on Feb 2.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(05)73218-9